Shares of Inogen INGN were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 73.33% over the past year to $0.12, which beat the estimate of ($0.06).
Revenue of $71,691,000 declined by 29.06% from the same period last year, which missed the estimate of $79,960,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Inogen hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Aug 04, 2020
Time: 04:30 PM
ET Webcast URL: https://investor.inogen.com/news-events/ir-calendar
Recent Stock Performance
Company's 52-week high was at $76.89
Company's 52-week low was at $29.28
Price action over last quarter: down 22.44%
Company Profile
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
